ALPCO’s Post

🔬 Discover the potential of #MonoclonalAntibody (mAb) technology and how it reflects our ambition in #Immunoscience at Sanofi. Innovative developments in mAb technology are paving the way for targeted treatments of chronic inflammatory diseases. This approach is also showing promise as a preventive tool against certain infectious diseases, such as bronchiolitis caused by Respiratory Syncytial Virus #RSV 🦠 Immunoscience holds promise to redefine R&D as we know it ✨To be continued…

Infectious Disease Clinical Trials: Navigating Innovation & Rising Complexity | Read it now: https://ow.ly/G74k50SgXfy. Biopharma industry experts share their insights on the evolving landscape for infectious disease R&D and how to achieve future success in this roundtable summary in partnership with Cerba Research. #InfectiousDisease #Biopharma #ClinicalResearch #CerbaResearch #HealthcareInnovation #ClinicalTrials

Today marks Day 1 of the 5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference in London. Shahriar, Nicole and Haroon will be available on the stand to discuss all of your diagnostic requirements. #rbiopharm #rbiopharmrhone #ausdiagnostics #clinicaldiagnostics

#Interleukin-6 (IL-6) is an #inflammatory biomarker that is widely used in a variety of clinical areas, including the diagnosis of #inflammation and #infection, the monitoring of #autoimmunediseases, and the assessment of tumor-related diseases.

Immune Thrombocytopenia: ACVIM Consensus Update and Diagnostic Strategies 🐕 🐾⚕👩🏻⚕️🩹dvm360® 💁🏻♀️Generally speaking, the most sensitive way to test for vector-borne disease agents that circulate in peripheral blood is what? 👩⚕️ Combining PCR with testing for antibody 💁🏻♀️ In a dog with melena and a verified platelet count of 90,000/uL, what is likely? 👩⚕️ The melena (consumption) is likely the cause of the thrombocytopenia 💁🏻♀️ Evaluating this can help differentiate ITP from non-immune causes of thrombocytopenia. 👩⚕️ ✅ the magnitude of the platelet count ✅ the results of PT and PTT testing ✅ whether otherwise unexplained pancytopenia is present ✅ whether vasculitis or sepsis is present 💁🏻♀️ In the diagnostic assessment of verified thrombocytopenia, helpful localizations to consider include what? 👩⚕️ ✅ Decreased production ✅ Consumption (DIC or hemorrhage) ✅ Immune-mediated destruction ✅ Sequestration 💁🏻♀️ The first step in the diagnostic assessment of thrombocytopenia is to perform what? 👩⚕️ A blood smear to verify the platelet count #ThrombocytopeniaUpdate #ACVIMConsensus #DiagnosticStrategies #PetHealthInsights #DVM360 #PlateletCountAssessment #VectorBorneDiseases

The winter season has brought with it an increase in the number of respiratory infections and the activity of the Respiratory Syncytial Virus (RSV) has been on the rise for weeks. While the RSV infection rate is showing signs of slowing in certain regions of the United States, various measures including hospitalization rates remain elevated. The most affected demographic groups tend to be young children and older adults. Throughout this period, tens of thousands of people have been admitted to hospitals for respiratory illnesses each week. According to the US Centers for Disease Control and Prevention, there were over 29,000 patients admitted with COVID-19*[1], approximately 15,000 with the flu, and thousands more with RSV*[2]. The importance of rapid, actionable diagnostics is vital to optimal patient management, especially during such times of heightened cases of respiratory infections. At Credo Diagnostics Biomedical, our solution – the VitaPCR™ Influenza/RSV Assay provides a real-time RT-PCR test for Flu A & B and RSV from a single sample in 20 minutes. Early detection and prompt treatment can make a significant difference in saving lives. Learn more about Credo’s VitaPCR™ instrument and assays: https://lnkd.in/g43QvWZD *Sources:  [1]: https://lnkd.in/dbSPemd  [2]: https://lnkd.in/eFj_Vv6 #RespiratorySyncytialVirus #globalhealth #CredoDiagnostics #VitaPCR #KnowledgeEmpoweringPeople 

🌟Trusted by hundreds of IVD customers🌟 #Interleukin6 (#IL6) is an #inflammatory biomarker that is widely used in a variety of clinical areas, including the diagnosis of #inflammation and #infection, the monitoring of #autoimmunediseases, and the assessment of tumor-related diseases. Enhance your inflammatory diagnostic tests with IL-6 raw materials from #NOVOPROTEIN. Our IL-6 #antibodies and #antigens are trusted by hundreds of IVD customers for their high clinical correlation, superior sensitivity, and excellent consistency for #diagnosis.👍 Learn more about our IL-6 product: https://lnkd.in/gKj4F2sP #NOVOPROTEIN #inflammatory #Interleukin6 #IL6 #immunodiagnostics #AutoimmuneDiseases #antibodies #antigens #diagnosis #inflammation #infection

No doubt we are facing a deep shift in our research! Sanofi is pioneering the future of medicine with #MonoclonalAntibody (mAb), a key technology of our #Immunoscience ambition. 🔬 Our latest video highlights how mAb technology is creating breakthroughs in treating chronic inflammatory diseases and holds promise for preventing infectious diseases like bronchiolitis caused by Respiratory Syncytial Virus #RSV 🦠 Are you now a mAb expert? ✨

It is estimated that 70% of healthcare decisions affecting diagnosis and treatment involve a pathology investigation. Without diagnostics, treating even basic infections with the appropriate medications becomes difficult if not impossible. This prospect is only worsened by the emergence of Multi Drug Resistant Organisms and enhances the need for better quality diagnostics! Discover the potential consequences of undiagnosed infectious diseases in this insightful article by bioMérieux.

February 29 is the rarest day of the year -- and it is also Rare Disease Day. #RareDiseaseDay2024 recognizes the global movement to change and improve lives of the 300 million people worldwide diagnosed with a rare disease. Rare Disease Facts: A disease is rare when it affects fewer than 1 in 2,000 people 70% of rare diseases start in childhood More than 6,000 rare diseases have been identified 72% of rare diseases are genetic At Valuate we are proud to collaborate with #pharma and #biotech manufacturers to help patients diagnosed with a rare disease gain access to life-changing therapies and treatments. Learn more about #rarediseaseday here: https://lnkd.in/gk6hbAF